Table 3.
Sex-specific clinical features and biochemical profile of PDB in China.
| Male | Female | P | |
|---|---|---|---|
| No. | 31 | 19 | - |
| Age at onset a | 45.60 ± 9.00 | 52.79 ± 17.61 | 0.212 |
| Age at clinical diagnosis a | 56.83 ± 15.84 | 57.58 ± 15.64 | 0.839 |
| ALP (U/L) a | 466.95 ± 429.59 c | 421.95 ± 490.60 | 0.371 |
| Number of affected skeletal sites b | 2 (1.00-4.00) | 2 (1.00-3.00) | 0.137 |
| Asymptomatic (%) | 2 (6.45) | 1 (3.23) | 0.609 |
| Monostotic (%) | 9 (29.03) | 9 (47.39) | 0.190 |
No.: Number; ALP, total alkaline phosphatase.
a
Data are showed as mean ± standard deviation (range).
b
Data are showed as median (25th and 75th percentiles).
c
Except for one patient who was previously treated with zoledronic acid before coming to our unit).
*p < 0.05 between male and female group.